🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an efficacy and safety study to compare aprepitant with ondansetron...
Status
Completed
Location
Multiple Locations
Start Date
2012-12-12
Trial ID
NCT01636947
The purpose of the Phase 1 part of the study is to determine the maximum to...
Status
Terminated
Location
California Cancer Associates For Research and Exellence, cCare
Start Date
2014-07-30
Trial ID
NCT01999335
Treatments Being Tested
Establishment of safety profile of HuMax-CD38 when given as monotherapy in ...
Status
Completed
Location
Multiple Locations
Start Date
2008-03-26
Trial ID
NCT00574288
Treatments Being Tested
Multicentric phase II trial to evaluate efficacy and safety of ibrutinib in...
Status
Completed
Location
Hospital Universitario Son Espases
Start Date
2016-04-07
Trial ID
NCT02692248
Treatments Being Tested
This is a Phase 1/2 study evaluating the safety and anti-tumor activity of ...
Status
Completed
Location
Northwestern Medical Faculty Foundation
Start Date
2008-01
Trial ID
NCT00555906
Treatments Being Tested
This protocol is an international, multicenter, comparative, open and rando...
Status
Unknown
Location
Hospital Universitário Clementino Fraga Filho
Start Date
2007-01
Trial ID
NCT01532856
This is an open label, multicenter, dose escalation, phase Ib study to dete...
Status
Completed
Location
Institut Jules Bordet
Start Date
2016-10
Trial ID
NCT02741388
Treatments Being Tested
This study will test how effective the drug, Carfilzomib, reduces progressi...
Status
Completed
Location
Birmingham VA Medical Center
Start Date
2014-04
Trial ID
NCT02047253
Treatments Being Tested
Eligible participants with newly diagnosed myeloma who are not considered e...
Status
Recruiting
Location
Gundersen Lutheran
Start Date
2026-09
Trial ID
NCT07285239
Our hypothesis is that treating relapsed or refractory multiple myeloma wit...
Status
Terminated
Location
Weill Cornell Medical College
Start Date
2014-02
Trial ID
NCT02030483
Treatments Being Tested